These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33563485)

  • 1. Breath profile as composite biomarkers for lung cancer diagnosis.
    Zou Y; Wang Y; Jiang Z; Zhou Y; Chen Y; Hu Y; Jiang G; Xie D
    Lung Cancer; 2021 Apr; 154():206-213. PubMed ID: 33563485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Confounding effect of benign pulmonary diseases in selecting volatile organic compounds as markers of lung cancer.
    Wang M; Sheng J; Wu Q; Zou Y; Hu Y; Ying K; Wan H; Wang P
    J Breath Res; 2018 Sep; 12(4):046013. PubMed ID: 30102249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
    Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
    Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of recent developments in determining volatile organic compounds in exhaled breath as biomarkers for lung cancer diagnosis.
    Zhou J; Huang ZA; Kumar U; Chen DDY
    Anal Chim Acta; 2017 Dec; 996():1-9. PubMed ID: 29137702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exhaled biomarkers in lung cancer.
    Horváth I; Lázár Z; Gyulai N; Kollai M; Losonczy G
    Eur Respir J; 2009 Jul; 34(1):261-75. PubMed ID: 19567608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calculated indices of volatile organic compounds (VOCs) in exhalation for lung cancer screening and early detection.
    Chen X; Muhammad KG; Madeeha C; Fu W; Xu L; Hu Y; Liu J; Ying K; Chen L; Yurievna GO
    Lung Cancer; 2021 Apr; 154():197-205. PubMed ID: 33653598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in the development of volatile exhaled breath signatures of lung cancer.
    Mazzone PJ; Wang XF; Lim S; Jett J; Choi H; Zhang Q; Beukemann M; Seeley M; Martino R; Rhodes P
    Ann Am Thorac Soc; 2015 May; 12(5):752-7. PubMed ID: 25965541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis by Volatile Organic Compounds in Exhaled Breath from Lung Cancer Patients Using Support Vector Machine Algorithm.
    Sakumura Y; Koyama Y; Tokutake H; Hida T; Sato K; Itoh T; Akamatsu T; Shin W
    Sensors (Basel); 2017 Feb; 17(2):. PubMed ID: 28165388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blinded Validation of Breath Biomarkers of Lung Cancer, a Potential Ancillary to Chest CT Screening.
    Phillips M; Bauer TL; Cataneo RN; Lebauer C; Mundada M; Pass HI; Ramakrishna N; Rom WN; Vallières E
    PLoS One; 2015; 10(12):e0142484. PubMed ID: 26698306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exhaled breath condensate biomarkers for lung cancer.
    Campanella A; De Summa S; Tommasi S
    J Breath Res; 2019 Aug; 13(4):044002. PubMed ID: 31282387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breath carbonyl compounds as biomarkers of lung cancer.
    Li M; Yang D; Brock G; Knipp RJ; Bousamra M; Nantz MH; Fu XA
    Lung Cancer; 2015 Oct; 90(1):92-7. PubMed ID: 26233567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of exhaled carbonyl compounds distinguishes benign from malignant pulmonary disease.
    Bousamra M; Schumer E; Li M; Knipp RJ; Nantz MH; van Berkel V; Fu XA
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1074-80; discussion 1080-1. PubMed ID: 25129599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Volatile signature for the early diagnosis of lung cancer.
    Gasparri R; Santonico M; Valentini C; Sedda G; Borri A; Petrella F; Maisonneuve P; Pennazza G; D'Amico A; Di Natale C; Paolesse R; Spaggiari L
    J Breath Res; 2016 Feb; 10(1):016007. PubMed ID: 26857451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High performance exhaled breath biomarkers for diagnosis of lung cancer and potential biomarkers for classification of lung cancer.
    Long Y; Wang C; Wang T; Li W; Dai W; Xie S; Tian Y; Liu M; Liu Y; Peng X; Liu Y; Zhang Y; Wang R; Li Q; Duan Y
    J Breath Res; 2021 Feb; 15(1):016017. PubMed ID: 33586667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Metal Oxide Gas Sensors Array for Lung Cancer Diagnosis Through Exhaled Breath Analysis.
    Marzorati D; Mainardi L; Sedda G; Gasparri R; Spaggiari L; Cerveri P
    Annu Int Conf IEEE Eng Med Biol Soc; 2019 Jul; 2019():1584-1587. PubMed ID: 31946198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exhaled metabolic markers and relevant dysregulated pathways of lung cancer: a pilot study.
    Zou Y; Hu Y; Jiang Z; Chen Y; Zhou Y; Wang Z; Wang Y; Jiang G; Tan Z; Hu F
    Ann Med; 2022 Dec; 54(1):790-802. PubMed ID: 35261323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung cancer biomarkers in exhaled breath.
    Amann A; Corradi M; Mazzone P; Mutti A
    Expert Rev Mol Diagn; 2011 Mar; 11(2):207-17. PubMed ID: 21405971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Targeted and Untargeted Approaches in Breath Analysis for the Discrimination of Lung Cancer from Benign Pulmonary Diseases and Healthy Persons.
    Koureas M; Kalompatsios D; Amoutzias GD; Hadjichristodoulou C; Gourgoulianis K; Tsakalof A
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33946997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infrared cavity ring-down spectroscopy for detecting non-small cell lung cancer in exhaled breath.
    Larracy R; Phinyomark A; Scheme E
    J Breath Res; 2022 Mar; 16(2):. PubMed ID: 35294929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic biomarkers for lung cancer prevention.
    Gasparri R; Romano R; Sedda G; Borri A; Petrella F; Galetta D; Casiraghi M; Spaggiari L
    J Breath Res; 2018 Feb; 12(2):027111. PubMed ID: 29033394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.